MeSH Review:
HIV
- The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Waldmann, T.A., Tagaya, Y. Annu. Rev. Immunol. (1999)
- Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. Staszewski, S., Morales-Ramirez, J., Tashima, K.T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D.F., Farina, D., Manion, D.J., Ruiz, N.M. N. Engl. J. Med. (1999)
- DNA deamination mediates innate immunity to retroviral infection. Harris, R.S., Bishop, K.N., Sheehy, A.M., Craig, H.M., Petersen-Mahrt, S.K., Watt, I.N., Neuberger, M.S., Malim, M.H. Cell (2003)
- A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. Abrams, D.I., Goldman, A.I., Launer, C., Korvick, J.A., Neaton, J.D., Crane, L.R., Grodesky, M., Wakefield, S., Muth, K., Kornegay, S. N. Engl. J. Med. (1994)
- The effects on survival of early treatment of human immunodeficiency virus infection. Graham, N.M., Zeger, S.L., Park, L.P., Vermund, S.H., Detels, R., Rinaldo, C.R., Phair, J.P. N. Engl. J. Med. (1992)
- NF-kappa B activates the HIV promoter in neurons. Rattner, A., Korner, M., Walker, M.D., Citri, Y. EMBO J. (1993)
- Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Benos, D.J., Hahn, B.H., Bubien, J.K., Ghosh, S.K., Mashburn, N.A., Chaikin, M.A., Shaw, G.M., Benveniste, E.N. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Levy, D.N., Refaeli, Y., MacGregor, R.R., Weiner, D.B. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Malnati, M., Broccolo, F., Nozza, S., Sarmati, L., Ghezzi, S., Locatelli, G., Delfanti, F., Capiluppi, B., Careddu, A., Andreoni, M., Monini, P., Poli, G., Lazzarin, A., Lusso, P., Tambussi, G. Blood (2002)
- Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Feucht, H.H., Zöllner, B., Polywka, S., Knödler, B., Schröter, M., Nolte, H., Laufs, R. Hepatology (1997)
- The biology of chemokines and their receptors. Rossi, D., Zlotnik, A. Annu. Rev. Immunol. (2000)
- The CD4-gp120 interaction and AIDS pathogenesis. Capon, D.J., Ward, R.H. Annu. Rev. Immunol. (1991)
- The protein network of HIV budding. von Schwedler, U.K., Stuchell, M., Müller, B., Ward, D.M., Chung, H.Y., Morita, E., Wang, H.E., Davis, T., He, G.P., Cimbora, D.M., Scott, A., Kräusslich, H.G., Kaplan, J., Morham, S.G., Sundquist, W.I. Cell (2003)
- AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Strack, B., Calistri, A., Craig, S., Popova, E., Göttlinger, H.G. Cell (2003)
- Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. Albrecht, M.A., Bosch, R.J., Hammer, S.M., Liou, S.H., Kessler, H., Para, M.F., Eron, J., Valdez, H., Dehlinger, M., Katzenstein, D.A. N. Engl. J. Med. (2001)
- Primary infection with zidovudine-resistant HIV. Hermans, P., Sprecher, S., Clumeck, N. N. Engl. J. Med. (1993)
- Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. Eron, J.J., Benoit, S.L., Jemsek, J., MacArthur, R.D., Santana, J., Quinn, J.B., Kuritzkes, D.R., Fallon, M.A., Rubin, M. N. Engl. J. Med. (1995)
- A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. Kahn, J.O., Lagakos, S.W., Richman, D.D., Cross, A., Pettinelli, C., Liou, S.H., Brown, M., Volberding, P.A., Crumpacker, C.S., Beall, G. N. Engl. J. Med. (1992)
- Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. Ellerbrock, T.V., Lieb, S., Harrington, P.E., Bush, T.J., Schoenfisch, S.A., Oxtoby, M.J., Howell, J.T., Rogers, M.F., Witte, J.J. N. Engl. J. Med. (1992)
- Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. Gulick, R.M., Mellors, J.W., Havlir, D., Eron, J.J., Gonzalez, C., McMahon, D., Richman, D.D., Valentine, F.T., Jonas, L., Meibohm, A., Emini, E.A., Chodakewitz, J.A. N. Engl. J. Med. (1997)
- Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cullen, B.R. Cell (1986)
- A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. Volberding, P.A., Lagakos, S.W., Grimes, J.M., Stein, D.S., Rooney, J., Meng, T.C., Fischl, M.A., Collier, A.C., Phair, J.P., Hirsch, M.S. N. Engl. J. Med. (1995)
- Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV. Bayer, R. N. Engl. J. Med. (1994)
- Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. Masur, H. N. Engl. J. Med. (1993)
- Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., De Wilde, M. Cell (1989)
- Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. Duncan, R.A., von Reyn, C.F., Alliegro, G.M., Toossi, Z., Sugar, A.M., Levitz, S.M. N. Engl. J. Med. (1993)
- Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Stevenson, M., Meier, C., Mann, A.M., Chapman, N., Wasiak, A. Cell (1988)
- A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Camerini, D., Seed, B. Cell (1990)
- Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. Pizzo, P.A., Eddy, J., Falloon, J., Balis, F.M., Murphy, R.F., Moss, H., Wolters, P., Brouwers, P., Jarosinski, P., Rubin, M. N. Engl. J. Med. (1988)
- A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Deen, K.C., McDougal, J.S., Inacker, R., Folena-Wasserman, G., Arthos, J., Rosenberg, J., Maddon, P.J., Axel, R., Sweet, R.W. Nature (1988)
- A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, S.C., Parmentier, M., Collman, R.G., Doms, R.W. Cell (1996)
- The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Michael, N.L., Louie, L.G., Rohrbaugh, A.L., Schultz, K.A., Dayhoff, D.E., Wang, C.E., Sheppard, H.W. Nat. Med. (1997)
- Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Herbein, G., Mahlknecht, U., Batliwalla, F., Gregersen, P., Pappas, T., Butler, J., O'Brien, W.A., Verdin, E. Nature (1998)
- HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Moses, A.V., Williams, S.E., Strussenberg, J.G., Heneveld, M.L., Ruhl, R.A., Bakke, A.C., Bagby, G.C., Nelson, J.A. Nat. Med. (1997)
- Alterations in a yeast protein resembling HIV Tat-binding protein relieve requirement for an acidic activation domain in GAL4. Swaffield, J.C., Bromberg, J.F., Johnston, S.A. Nature (1992)
- Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M.J., VanDyke, R., Bey, M., Shearer, W., Jacobson, R.L. N. Engl. J. Med. (1994)
- The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. Burgard, M., Mayaux, M.J., Blanche, S., Ferroni, A., Guihard-Moscato, M.L., Allemon, M.C., Ciraru-Vigneron, N., Firtion, G., Floch, C., Guillot, F. N. Engl. J. Med. (1992)
- Vaccination with gp160 in HIV. Oyaizu, N., Chirmule, N., Pahwa, S. N. Engl. J. Med. (1992)
- A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. Spector, S.A., Gelber, R.D., McGrath, N., Wara, D., Barzilai, A., Abrams, E., Bryson, Y.J., Dankner, W.M., Livingston, R.A., Connor, E.M. N. Engl. J. Med. (1994)
- A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. Roddy, R.E., Zekeng, L., Ryan, K.A., Tamoufé, U., Weir, S.S., Wong, E.L. N. Engl. J. Med. (1998)